Paper23313617
Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains.
Westdijk J and 8 others. Vaccine, 2013. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains. Papers, record 23313617. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23313617
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adjuvants, Immunologic | Major topic |
| Poliovirus | Major topic |
| Poliovirus Vaccines | Major topic |
| Animals | |
| Antibodies, Neutralizing | |
| Antibodies, Viral | |
| Neutralization Tests | |
| Poliovirus Vaccine, Inactivated | |
| Rats |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U01 AI070976 | NIAID NIH HHS | United States | U01AI070976 | PubMed and NIH |
| U01-AI070976 | NIAID NIH HHS | United States | U01AI070976 | PubMed and NIH |
Source NIH RePORTER
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22531556 | Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles. | Vaccine | 2012 | https://conductscience.org/library/papers/22531556 | PubMed |
| 2 | 12899574 | Development of RTS,S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant. | Expert Rev Vaccines | 2003 | https://conductscience.org/library/papers/12899574 | PubMed |
| 3 | 18440205 | Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsions. | Colloids Surf B Biointerfaces | 2008 | https://conductscience.org/library/papers/18440205 | PubMed |
| 4 | 21684427 | The Vaccine Formulation Laboratory: a platform for access to adjuvants. | Vaccine | 2011 | https://conductscience.org/library/papers/21684427 | PubMed |
| 5 | 16425140 | 1,25-dihydroxyvitamin d3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice. | J Infect Dis | 2006 | https://conductscience.org/library/papers/16425140 | PubMed |
| 6 | 22415641 | Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions. | AAPS PharmSciTech | 2012 | https://conductscience.org/library/papers/22415641 | PubMed |
| 7 | 21906648 | Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions. | Vaccine | 2011 | https://conductscience.org/library/papers/21906648 | PubMed |
| 8 | 9434729 | Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. | Virology | 1997 | https://conductscience.org/library/papers/9434729 | PubMed |
| 9 | 1845806 | Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines. | J Infect Dis | 1991 | https://conductscience.org/library/papers/1845806 | PubMed |
| 10 | 10590126 | Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles. | J Virol | 2000 | https://conductscience.org/library/papers/10590126 | PubMed |
| 11 | 19729087 | CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus. | Vaccine | 2009 | https://conductscience.org/library/papers/19729087 | PubMed |
| 12 | 16505353 | Mucosal and systemic adjuvant activity of alphavirus replicon particles. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16505353 | PubMed |
| 13 | 20550484 | Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions. | Pharm Dev Technol | 2011 | https://conductscience.org/library/papers/20550484 | PubMed |
| 14 | 2053280 | Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. | Virology | 1991 | https://conductscience.org/library/papers/2053280 | PubMed |
| 15 | 18704954 | Vaccine adjuvants: current challenges and future approaches. | J Pharm Sci | 2009 | https://conductscience.org/library/papers/18704954 | PubMed |
| 16 | 22884665 | Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia. | Vaccine | 2013 | https://conductscience.org/library/papers/22884665 | PubMed |
| 17 | 20184975 | Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization. | Vaccine | 2010 | https://conductscience.org/library/papers/20184975 | PubMed |
| 18 | 6262142 | Potency testing of killed polio vaccine in rats. | Dev Biol Stand | 1981 | https://conductscience.org/library/papers/6262142 | PubMed |
| 19 | 11226454 | Immunoglobulin subclass responses of wild brown rats to Sarcocystis singaporensis. | Int J Parasitol | 2001 | https://conductscience.org/library/papers/11226454 | PubMed |
| 20 | 21162624 | Combination adjuvants: the next generation of adjuvants? | Expert Rev Vaccines | 2011 | https://conductscience.org/library/papers/21162624 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36576132 | Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication. | Hum Vaccin Immunother | 2022 | https://conductscience.org/library/papers/36576132 | PubMed |
| 35968964 | RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge. | mSphere | 2022 | https://conductscience.org/library/papers/35968964 | PubMed |
| 35563292 | Low-Dose SARS-CoV-2 S-Trimer with an Emulsion Adjuvant Induced Th1-Biased Protective Immunity. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35563292 | PubMed |
| 33066050 | In-Vitro Inactivation of Sabin-Polioviruses for Development of Safe and Effective Polio Vaccine. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/33066050 | PubMed |
| 32411401 | H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets. | NPJ Vaccines | 2020 | https://conductscience.org/library/papers/32411401 | PubMed |
| 29601259 | Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV). | Hum Vaccin Immunother | 2018 | https://conductscience.org/library/papers/29601259 | PubMed |
| 28794452 | The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin. | Sci Rep | 2017 | https://conductscience.org/library/papers/28794452 | PubMed |
| 27470209 | Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine. | Vaccine | 2016 | https://conductscience.org/library/papers/27470209 | PubMed |
| 27317570 | Determination of Depth-Dependent Intradermal Immunogenicity of Adjuvanted Inactivated Polio Vaccine Delivered by Microinjections via Hollow Microneedles. | Pharm Res | 2016 | https://conductscience.org/library/papers/27317570 | PubMed |
| 27066157 | Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies. | Trials Vaccinol | 2015 | https://conductscience.org/library/papers/27066157 | PubMed |
| 25483682 | Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system. | Hum Vaccin Immunother | 2014 | https://conductscience.org/library/papers/25483682 | PubMed |
| 24956110 | Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01. | PLoS One | 2014 | https://conductscience.org/library/papers/24956110 | PubMed |
| 24760448 | Development of thermostable lyophilized inactivated polio vaccine. | Pharm Res | 2014 | https://conductscience.org/library/papers/24760448 | PubMed |
| 24469907 | Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats. | Pharm Res | 2014 | https://conductscience.org/library/papers/24469907 | PubMed |
| 24349497 | Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals. | PLoS One | 2013 | https://conductscience.org/library/papers/24349497 | PubMed |
| 24333345 | A mucosal adjuvant for the inactivated poliovirus vaccine. | Vaccine | 2014 | https://conductscience.org/library/papers/24333345 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23313617
GET https://conductscience.org/api/papers/v1/23313617/references?page=2